 |
PDBsum entry 1v0d
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Mol Cell
14:531-539
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural mechanism for inactivation and activation of CAD/DFF40 in the apoptotic pathway.
|
|
E.J.Woo,
Y.G.Kim,
M.S.Kim,
W.D.Han,
S.Shin,
H.Robinson,
S.Y.Park,
B.H.Oh.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
CAD/DFF40 is responsible for the degradation of chromosomal DNA into nucleosomal
fragments and subsequent chromatin condensation during apoptosis. It exists as
an inactive complex with its inhibitor ICAD/DFF45 in proliferating cells but
becomes activated upon cleavage of ICAD/DFF45 into three domains by caspases in
dying cells. The molecular mechanism underlying the control and activation of
CAD/DFF40 was unknown. Here, the crystal structure of activated CAD/DFF40
reveals that it is a pair of molecular scissors with a deep active-site crevice
that appears ideal for distinguishing internucleosomal DNA from nucleosomal DNA.
Ensuing studies show that ICAD/DFF45 sequesters the nonfunctional CAD/DFF40
monomer and is also able to disassemble the functional CAD/DFF40 dimer. This
capacity requires the involvement of the middle domain of ICAD/DFF45, which by
itself cannot remain bound to CAD/DFF40 due to low binding affinity for the
enzyme. Thus, the consequence of the caspase-cleavage of ICAD/DFF45 is a
self-assembly of CAD/DFF40 into the active dimer.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Structural Aspects of CAD(A) The monomeric
structure. The secondary structures in Domains C2 and C3 are
numbered in the order of appearance in the primary sequence. The
invisible Domain C1 is represented as a sphere. The
catalytically important histidine and lysine residues are shown
in ball-and-sticks. The Zn^2+ binding site is shown with the
Zn^2+ in orange and the cysteinyl sulfur in yellow. The inset
shows the detailed interactions of the catalytic residues
together with the final 2F[o] − F[c] electron density map
(2.6 Å, 1.0 σ). The putative Mg^2+ is represented as a
yellow sphere. Asp262, His308, and two loosely bound water
molecules provide the metal coordination arms. Asn260 and a
water molecule are on the hydrogen-bonded network with a
metal-coordinating water.(B) The dimeric structure. In the side
view (top), one subunit in blue is oriented similar to that in
(A). The catalytic residues and the Zn^2+ binding site are
shown. A DNA strand shows CAD on the same scale. The top view
(bottom) is looking down along the molecular 2-fold axis. The
crevice between the C3 domains spans 14 base pairs of the
modeled DNA. Of note, the longest helix α4 fits into the major
groove of the DNA.
|
 |
Figure 4.
Figure 4. Estimation of Molecular WeightThe apparent
molecular weight of each indicated complex was analyzed with a
HiLoad 26/60 Superdex 75 column. The proteins were eluted at a
rate of 1.5 ml/min with 30 mM TrisHCl buffer (pH 8.0) containing
100 mM NaCl and 3 mM dithiothreitol. For clarity, the elution
profiles for only CAD:ICAD and CAD are shown. The size marker
proteins were the TRAIL:DR5 complex (99 kDa), albumin (66 kDa),
ovalbumin (45 kDa), chymotrypsinogen (25 kDa), and ribonuclease
A (14 kDa). The calculated molecular weights of CAD, ICAD-L,
ICAD-S, I1, I1-I2, and I2-I3 that we generated are 37.53, 34.42,
28.77, 12.87, 24.76, and 21.56 kDa, respectively.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Mol Cell
(2004,
14,
531-539)
copyright 2004.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Andrady,
S.K.Sharma,
and
K.A.Chester
(2011).
Antibody-enzyme fusion proteins for cancer therapy.
|
| |
Immunotherapy,
3,
193-211.
|
 |
|
|
|
|
 |
I.Kitazumi,
and
M.Tsukahara
(2011).
Regulation of DNA fragmentation: the role of caspases and phosphorylation.
|
| |
FEBS J,
278,
427-441.
|
 |
|
|
|
|
 |
W.Yang
(2011).
Nucleases: diversity of structure, function and mechanism.
|
| |
Q Rev Biophys,
44,
1.
|
 |
|
|
|
|
 |
S.J.McBryant,
X.Lu,
and
J.C.Hansen
(2010).
Multifunctionality of the linker histones: an emerging role for protein-protein interactions.
|
| |
Cell Res,
20,
519-528.
|
 |
|
|
|
|
 |
B.He,
N.Lu,
and
Z.Zhou
(2009).
Cellular and nuclear degradation during apoptosis.
|
| |
Curr Opin Cell Biol,
21,
900-912.
|
 |
|
|
|
|
 |
L.J.Wee,
J.C.Tong,
T.W.Tan,
and
S.Ranganathan
(2009).
A multi-factor model for caspase degradome prediction.
|
| |
BMC Genomics,
10,
S6.
|
 |
|
|
|
|
 |
M.Mathew,
and
R.S.Verma
(2009).
Humanized immunotoxins: a new generation of immunotoxins for targeted cancer therapy.
|
| |
Cancer Sci,
100,
1359-1365.
|
 |
|
|
|
|
 |
C.E.Johnson,
and
S.Kornbluth
(2008).
Caspase cleavage is not for everyone.
|
| |
Cell,
134,
720-721.
|
 |
|
|
|
|
 |
C.Wu,
Y.Zhang,
Z.Sun,
and
P.Li
(2008).
Molecular evolution of Cide family proteins: novel domain formation in early vertebrates and the subsequent divergence.
|
| |
BMC Evol Biol,
8,
159.
|
 |
|
|
|
|
 |
J.Hanus,
M.Kalinowska-Herok,
and
P.Widlak
(2008).
The major apoptotic endonuclease DFF40/CAD is a deoxyribose-specific and double-strand-specific enzyme.
|
| |
Apoptosis,
13,
377-382.
|
 |
|
|
|
|
 |
S.Nagata
(2008).
Rheumatoid polyarthritis caused by a defect in DNA degradation.
|
| |
Cytokine Growth Factor Rev,
19,
295-302.
|
 |
|
|
|
|
 |
W.Yang
(2008).
An equivalent metal ion in one- and two-metal-ion catalysis.
|
| |
Nat Struct Mol Biol,
15,
1228-1231.
|
 |
|
|
|
|
 |
A.V.Ageichik,
K.Samejima,
S.H.Kaufmann,
and
W.C.Earnshaw
(2007).
Genetic analysis of the short splice variant of the inhibitor of caspase-activated DNase (ICAD-S) in chicken DT40 cells.
|
| |
J Biol Chem,
282,
27374-27382.
|
 |
|
|
|
|
 |
F.Xiao,
P.Widlak,
and
W.T.Garrard
(2007).
Engineered apoptotic nucleases for chromatin research.
|
| |
Nucleic Acids Res,
35,
e93.
|
 |
|
|
|
|
 |
J.C.Timmer,
and
G.S.Salvesen
(2007).
Caspase substrates.
|
| |
Cell Death Differ,
14,
66-72.
|
 |
|
|
|
|
 |
S.Nagata
(2007).
Autoimmune diseases caused by defects in clearing dead cells and nuclei expelled from erythroid precursors.
|
| |
Immunol Rev,
220,
237-250.
|
 |
|
|
|
|
 |
S.R.Dunn,
C.E.Schnitzler,
and
V.M.Weis
(2007).
Apoptosis and autophagy as mechanisms of dinoflagellate symbiont release during cnidarian bleaching: every which way you lose.
|
| |
Proc Biol Sci,
274,
3079-3085.
|
 |
|
|
|
|
 |
C.H.Lu,
Y.S.Lin,
Y.C.Chen,
C.S.Yu,
S.Y.Chang,
and
J.K.Hwang
(2006).
The fragment transformation method to detect the protein structural motifs.
|
| |
Proteins,
63,
636-643.
|
 |
|
|
|
|
 |
P.Widlak,
and
W.T.Garrard
(2006).
The apoptotic endonuclease DFF40/CAD is inhibited by RNA, heparin and other polyanions.
|
| |
Apoptosis,
11,
1331-1337.
|
 |
|
|
|
|
 |
P.Widlak,
and
W.T.Garrard
(2006).
Unique features of the apoptotic endonuclease DFF40/CAD relative to micrococcal nuclease as a structural probe for chromatin.
|
| |
Biochem Cell Biol,
84,
405-410.
|
 |
|
|
|
|
 |
S.R.Dunn,
W.S.Phillips,
J.W.Spatafora,
D.R.Green,
and
V.M.Weis
(2006).
Highly conserved caspase and Bcl-2 homologues from the sea anemone Aiptasia pallida: lower metazoans as models for the study of apoptosis evolution.
|
| |
J Mol Evol,
63,
95.
|
 |
|
|
|
|
 |
C.Korn,
S.R.Scholz,
O.Gimadutdinow,
R.Lurz,
A.Pingoud,
and
G.Meiss
(2005).
Interaction of DNA fragmentation factor (DFF) with DNA reveals an unprecedented mechanism for nuclease inhibition and suggests that DFF can be activated in a DNA-bound state.
|
| |
J Biol Chem,
280,
6005-6015.
|
 |
|
|
|
|
 |
D.Lechardeur,
S.Dougaparsad,
C.Nemes,
and
G.L.Lukacs
(2005).
Oligomerization state of the DNA fragmentation factor in normal and apoptotic cells.
|
| |
J Biol Chem,
280,
40216-40225.
|
 |
|
|
|
|
 |
G.Banfalvi,
M.Gacsi,
G.Nagy,
Z.B.Kiss,
and
A.G.Basnakian
(2005).
Cadmium induced apoptotic changes in chromatin structure and subphases of nuclear growth during the cell cycle in CHO cells.
|
| |
Apoptosis,
10,
631-642.
|
 |
|
|
|
|
 |
I.A.Cymerman,
G.Meiss,
and
J.M.Bujnicki
(2005).
DNase II is a member of the phospholipase D superfamily.
|
| |
Bioinformatics,
21,
3959-3962.
|
 |
|
|
|
|
 |
J.D.West,
C.Ji,
and
L.J.Marnett
(2005).
Modulation of DNA fragmentation factor 40 nuclease activity by poly(ADP-ribose) polymerase-1.
|
| |
J Biol Chem,
280,
15141-15147.
|
 |
|
|
|
|
 |
K.Samejima,
and
W.C.Earnshaw
(2005).
Trashing the genome: the role of nucleases during apoptosis.
|
| |
Nat Rev Mol Cell Biol,
6,
677-688.
|
 |
|
|
|
|
 |
M.Ghosh,
G.Meiss,
A.Pingoud,
R.E.London,
and
L.C.Pedersen
(2005).
Structural insights into the mechanism of nuclease A, a betabeta alpha metal nuclease from Anabaena.
|
| |
J Biol Chem,
280,
27990-27997.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Kalinowska,
W.Garncarz,
M.Pietrowska,
W.T.Garrard,
and
P.Widlak
(2005).
Regulation of the human apoptotic DNase/RNase endonuclease G: involvement of Hsp70 and ATP.
|
| |
Apoptosis,
10,
821-830.
|
 |
|
|
|
|
 |
N.Yan,
and
Y.Shi
(2005).
Mechanisms of apoptosis through structural biology.
|
| |
Annu Rev Cell Dev Biol,
21,
35-56.
|
 |
|
|
|
|
 |
P.Widlak,
and
W.T.Garrard
(2005).
Discovery, regulation, and action of the major apoptotic nucleases DFF40/CAD and endonuclease G.
|
| |
J Cell Biochem,
94,
1078-1087.
|
 |
|
|
|
|
 |
S.Nagata
(2005).
DNA degradation in development and programmed cell death.
|
| |
Annu Rev Immunol,
23,
853-875.
|
 |
|
|
|
|
 |
S.Reh,
C.Korn,
O.Gimadutdinow,
and
G.Meiss
(2005).
Structural basis for stable DNA complex formation by the caspase-activated DNase.
|
| |
J Biol Chem,
280,
41707-41715.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |